Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

The word OK began as a humorous abbreviation in the 1800s before becoming the most widely recognized phrase in the world. 35 shot, 5 dead, in Chicago amid Trump's threat to deploy National Guard 1.2M ...

Most people recognize Alzheimer's from its devastating symptoms such as memory loss, while new drugs target pathological aspects of disease manifestations, such as plaques of amyloid proteins. Now a ...

The new Cayenne Electric debuts wireless charging, so that you never forget to charge your EV again. Porsche wireless charging is finally here, and it’s debuting with the new Cayenne Electric in late ...

The Netherlands may be a country, but it often feels like one interconnected city. This documentary explores how its dense population, transport systems, and urban design make it unlike anywhere else ...

Novel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly ...

The Price to Earnings ratio of 37.15 is 0.43x lower than the industry average, indicating potential undervaluation for the stock. With a Price to Book ratio of 10.97, significantly falling below the ...

SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, ...

There has been a lot of positive buzz around the Boston Red Sox's front office recently. That is, of course, for some of the players that the club has brought in. Also, this is in reference to early ...